These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 7870039

  • 1. Characterization of two affinity states of adenosine A2a receptors with a new radioligand, 2-[2-(4-amino-3-[125I]iodophenyl)ethylamino]adenosine.
    Luthin DR, Olsson RA, Thompson RD, Sawmiller DR, Linden J.
    Mol Pharmacol; 1995 Feb; 47(2):307-13. PubMed ID: 7870039
    [Abstract] [Full Text] [Related]

  • 2. 125I-APE binding to adenosine receptors in coronary artery: photoaffinity labeling with 125I-azidoAPE.
    Hussain T, Linden J, Mustafa SJ.
    J Pharmacol Exp Ther; 1996 Jan; 276(1):284-8. PubMed ID: 8558444
    [Abstract] [Full Text] [Related]

  • 3. Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes.
    Nonaka H, Mori A, Ichimura M, Shindou T, Yanagawa K, Shimada J, Kase H.
    Mol Pharmacol; 1994 Nov; 46(5):817-22. PubMed ID: 7969067
    [Abstract] [Full Text] [Related]

  • 4. 125I-BW-A844U, an antagonist radioligand with high affinity and selectivity for adenosine A1 receptors, and 125I-azido-BW-A844U, a photoaffinity label.
    Patel A, Craig RH, Daluge SM, Linden J.
    Mol Pharmacol; 1988 Jun; 33(6):585-91. PubMed ID: 3380075
    [Abstract] [Full Text] [Related]

  • 5. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
    Dionisotti S, Ongini E, Zocchi C, Kull B, Arslan G, Fredholm BB.
    Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
    [Abstract] [Full Text] [Related]

  • 6. Photoaffinity labeling with 2(-)[2-(4-azido-3(-)[125I]- iodophenyl)ethylamino]adenosine and autoradiography with 2(-)[2-(4-amino-3(-)[125I]iodophenyl)ethylamino]adenosine of A2a adenosine receptors in rat brain.
    Luthin DR, Lee KS, Okonkwo D, Zhang P, Linden J.
    J Neurochem; 1995 Nov; 65(5):2072-9. PubMed ID: 7595492
    [Abstract] [Full Text] [Related]

  • 7. ZM241385 is an antagonist of the facilitatory responses produced by the A2A adenosine receptor agonists CGS21680 and HENECA in the rat hippocampus.
    Cunha RA, Constantino MD, Ribeiro JA.
    Br J Pharmacol; 1997 Dec; 122(7):1279-84. PubMed ID: 9421273
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A carboxyl-terminally truncated mutant and nonglycosylated A2a adenosine receptors retain ligand binding.
    Piersen CE, True CD, Wells JN.
    Mol Pharmacol; 1994 May; 45(5):861-70. PubMed ID: 8190103
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H]-SCH 58261 binding.
    Varani K, Gessi S, Dalpiaz A, Ongini E, Borea PA.
    Br J Pharmacol; 1997 Sep; 122(2):386-92. PubMed ID: 9313951
    [Abstract] [Full Text] [Related]

  • 16. A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase.
    Hide I, Padgett WL, Jacobson KA, Daly JW.
    Mol Pharmacol; 1992 Feb; 41(2):352-9. PubMed ID: 1311411
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists.
    Müller CE, Geis U, Hipp J, Schobert U, Frobenius W, Pawłowski M, Suzuki F, Sandoval-Ramírez J.
    J Med Chem; 1997 Dec 19; 40(26):4396-405. PubMed ID: 9435909
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.
    Labbé-Jullié C, Botto JM, Mas MV, Chabry J, Mazella J, Vincent JP, Gully D, Maffrand JP, Kitabgi P.
    Mol Pharmacol; 1995 May 19; 47(5):1050-6. PubMed ID: 7746272
    [Abstract] [Full Text] [Related]

  • 20. Novel 3-aralkyl-7-(amino-substituted)-1,2,3-triazolo[4,5-d]pyrimidines with high affinity toward A1 adenosine receptors.
    Betti L, Biagi G, Giannaccini G, Giorgi I, Livi O, Lucacchini A, Manera C, Scartoni V.
    J Med Chem; 1998 Feb 26; 41(5):668-73. PubMed ID: 9513594
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.